Log in to save to my catalogue

Integrated analysis of the genomic and transcriptional profile of gliomas with isocitrate dehydrogen...

Integrated analysis of the genomic and transcriptional profile of gliomas with isocitrate dehydrogen...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9669701

Integrated analysis of the genomic and transcriptional profile of gliomas with isocitrate dehydrogenase-1 and tumor protein 53 mutations

About this item

Full title

Integrated analysis of the genomic and transcriptional profile of gliomas with isocitrate dehydrogenase-1 and tumor protein 53 mutations

Publisher

London, England: SAGE Publications

Journal title

International journal of immunopathology and pharmacology, 2022-11, Vol.36, p.3946320221139262-3946320221139262

Language

English

Formats

Publication information

Publisher

London, England: SAGE Publications

More information

Scope and Contents

Contents

Background: The gene mutation of isocitrate dehydrogenase-1 (IDH1) is commonly found in LGG and some GBM patients and usually carries tumor protein 53 (TP53) mutations. However, the underlying mechanisms on both mutations of glioma patients in IDH1 and TP53 are still unclear. Aim: To find the potential target markers in GBM and LGG patients with ID...

Alternative Titles

Full title

Integrated analysis of the genomic and transcriptional profile of gliomas with isocitrate dehydrogenase-1 and tumor protein 53 mutations

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9669701

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9669701

Other Identifiers

ISSN

0394-6320

E-ISSN

2058-7384

DOI

10.1177/03946320221139262

How to access this item